Based on the MERCK KGAA NAM.SP.ADR stock forecast from 0 analysts, the average analyst target price for MERCK KGAA NAM.SP.ADR is not available over the next 12 months. MERCK KGAA NAM.SP.ADR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of MERCK KGAA NAM.SP.ADR is Slightly Bearish, which is based on 5 positive signals and 10 negative signals. At the last closing, MERCK KGAA NAM.SP.ADR’s stock price was EUR 27.20. MERCK KGAA NAM.SP.ADR’s stock price has changed by -3.55% over the past week, -1.45% over the past month and -2.16% over the last year.
No recent analyst target price found for MERCK KGAA NAM.SP.ADR
No recent average analyst rating found for MERCK KGAA NAM.SP.ADR
Company Overview MERCK KGAA NAM.SP.ADR
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. Its Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KGaA. Read Less
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as w...Read More
Frequently Asked Questions About MERCK KGAA NAM.SP.ADR (MRKC:F) Stock
Stock Target Advisor's fundamental analysis for MERCK KGAA NAM.SP.ADR's stock is Slightly Bearish.
MRKC:F stock's dividend yield is 1.46%.
Our analysis grades MRKC:F stock's dividend yield at F. This means that MRKC:F stock's dividend yield is above 15% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the F exchange.
Based on this MRKC:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on MRKC:F's stock to indicate what its average analyst target is.
MRKC:F stock's Price/Earning ratio is 22.26.
Our analysis grades MRKC:F stock's Price / Earning ratio at F. This means that MRKC:F stock's Price/Earning ratio is above 59.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the F exchange.
Based on this MRKC:F may be a overvalued for its sector.
The last closing price of MRKC:F's stock was EUR 27.20.
The most recent market capitalization for MRKC:F is EUR 60.85B.
Unfortunately we do not have enough analyst data on MRKC:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains MERCK KGAA NAM.SP.ADR's stock.
As per our most recent records MERCK KGAA NAM.SP.ADR has 62,176 Employees.
MERCK KGAA NAM.SP.ADR's registered address is Frankfurter Strasse 250, Darmstadt, Germany, 64293.
You can get more information about it from MERCK KGAA NAM.SP.ADR's website at https://www.merckgroup.com/en.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About MERCK KGAA NAM.SP.ADR (MRKC:F) Stock
Stock Target Advisor's fundamental analysis for MERCK KGAA NAM.SP.ADR's stock is Slightly Bearish.
MRKC:F stock's dividend yield is 1.46%.
Our analysis grades MRKC:F stock's dividend yield at F. This means that MRKC:F stock's dividend yield is above 15% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the F exchange.
Based on this MRKC:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on MRKC:F's stock to indicate what its average analyst target is.
MRKC:F stock's Price/Earning ratio is 22.26.
Our analysis grades MRKC:F stock's Price / Earning ratio at F. This means that MRKC:F stock's Price/Earning ratio is above 59.00000000000001% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the F exchange.
Based on this MRKC:F may be a overvalued for its sector.
The last closing price of MRKC:F's stock was EUR 27.20.
The most recent market capitalization for MRKC:F is EUR 60.85B.
Unfortunately we do not have enough analyst data on MRKC:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains MERCK KGAA NAM.SP.ADR's stock.
As per our most recent records MERCK KGAA NAM.SP.ADR has 62,176 Employees.
MERCK KGAA NAM.SP.ADR's registered address is Frankfurter Strasse 250, Darmstadt, Germany, 64293.
You can get more information about it from MERCK KGAA NAM.SP.ADR's website at https://www.merckgroup.com/en.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MRKC:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
